Subscriber Content Preview | Request a free trialSearch  
  Go

Entries tagged "MAP Pharmaceuticals Inc."

You have executed a tag search on The Deal Pipeline. Below, you will find a comprehensive list of stories tagged "MAP Pharmaceuticals Inc.."

3 result(s) displayed (1 - 3 of 3)


Delaware's full disclosure

Judges have developed a robust and occasionally contradictory body of law on what companies must reveal to shareholders about a sale. Continue reading

Posted on March 15, 2013 4:13 PM




Allergan wants to trim obesity treatment unit

The Irvine, Calif., pharmaceutical developer and producer of Botox will explore a sale of the business as sales continue to drop for its key product, the Lap-Band. Continue reading

Posted on February 8, 2013 3:11 PM




Allergan pays steep premium for migraine specialist

The drugmaker will acquire MAP Pharmaceuticals in deal that values the target's equity at $958 million, giving analysts who follow the buyer an aching head. Continue reading

Posted on January 23, 2013 4:20 PM






Movable Type search results powered by Fast Search



Popular tags




Movers & Shakers

Launch Movers and shakers slideshow

Ken deRegt will retire as head of fixed income at Morgan Stanley and be replaced by Michael Heaney and Robert Rooney. For other updates launch today's Movers & shakers slideshow.

Video

Coming back for more

Apax Partners offers $1.1 billion for Rue21, the same teenage fashion chain it took public in 2009. More video

Sectors